We are live on ! Find out more
CYT

Cyteir Therapeutics, Inc. Common Stock
CYT

Delisted

CYT was delisted on the 15th of March, 2024.

Back to rankings

48 hedge funds and large institutions have $253M invested in Cyteir Therapeutics, Inc. Common Stock in 2021 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 16 increasing their positions, 9 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 2

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

78% more repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 9

26% more funds holding

Funds holding: 38 → 48 (+10)

26% less capital invested

Capital invested by funds: $344M → $253M (-$90.7M)

Holders
48
Holders Change
+10
Holders Change %
+26.32%
% of All Funds
0.74%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
12
Increased
16
Reduced
9
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
APM
Avidity Partners Management
Texas
+$2.53M
2
BlackRock
BlackRock
New York
+$2.3M
3
Morgan Stanley
Morgan Stanley
New York
+$1.28M
4
Millennium Management
Millennium Management
New York
+$790K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$660K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$3.61M
2
CCM
CAAS Capital Management
New York
-$1.56M
3
SI
Sofinnova Investments
California
-$1.02M
4
SFM
Sphera Funds Management
Israel
-$553K
5
Citadel Advisors
Citadel Advisors
Florida
-$482K
Name Holding Trade Value Shares
Change 		Change in
Stake
Jane Street
26
Jane Street
New York
$180K +$241K +15,843 New
Bank of America
27
Bank of America
North Carolina
$175K +$46K +3,016 +24%
ACM
28
ACT Capital Management
Pennsylvania
$171K – – –
E
29
Ergoteles
New York
$152K +$204K +13,355 New
Goldman Sachs
30
Goldman Sachs
New York
$138K +$185K +12,137 New
N
31
Nuveen
North Carolina
$124K – – –
JP Morgan Chase
32
JP Morgan Chase
New York
$71K +$29K +1,903 +43%
New York State Common Retirement Fund
33
New York State Common Retirement Fund
New York
$68K +$91K +5,971 New
Deutsche Bank
34
Deutsche Bank
Germany
$58K +$4.12K +270 +6%
AIG
35
American International Group
New York
$51K -$2.03K -133 -3%
California State Teachers Retirement System (CalSTRS)
36
California State Teachers Retirement System (CalSTRS)
California
$51K – – –
Wells Fargo
37
Wells Fargo
California
$50K +$67K +4,393 +10,216%
Allspring Global Investments
38
Allspring Global Investments
North Carolina
$39K +$52.4K +3,441 New
SPIA
39
Steward Partners Investment Advisory
New York
$36K -$2.67K -175 -5%
Citigroup
40
Citigroup
New York
$36K +$29.3K +1,921 +157%
Royal Bank of Canada
41
Royal Bank of Canada
Ontario, Canada
$25K +$15.6K +1,022 +87%
TRCT
42
Tower Research Capital (TRC)
New York
$25K +$27.1K +1,781 +449%
SO
43
STRS Ohio
Ohio
$21K – – –
Legal & General Group
44
Legal & General Group
United Kingdom
$9K – – –
AIP
45
Ameritas Investment Partners
Nebraska
$7K – – –
HNWAG
46
High Net Worth Advisory Group
Florida
$6K +$7.62K +500 New
SOW
47
State of Wyoming
Wyoming
$1K -$30 -2 -4%
Daiwa Securities Group
48
Daiwa Securities Group
Japan
$1K +$1.57K +103 New
Citadel Advisors
49
Citadel Advisors
Florida
– -$482K -27,510 Closed
GCM
50
Ghisallo Capital Management
Massachusetts
– -$263K -15,000 Closed
1
2

CYT Hedge Fund Activity: Q4 2021 in Review

48 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in Cyteir Therapeutics, Inc. Common Stock (CYT) for Q4 2021, worth a combined $253M — down 26% from $344M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new CYT positions and 2 closed out — a net gain of 10 holders — while 16 added to existing stakes and 9 trimmed.

The largest buyer was Avidity Partners Management, adding an estimated $2.53M. The largest seller was Fidelity Investments, cutting an estimated $3.61M.

  • 48 institutional investors held Cyteir Therapeutics, Inc. Common Stock (CYT) as of Q4 2021, up from 38 in Q3 2021.
  • Funds reported $253M of Cyteir Therapeutics, Inc. Common Stock stock for Q4 2021, down 26% quarter-over-quarter.
  • 12 funds opened new Cyteir Therapeutics, Inc. Common Stock positions in Q4 2021 and 2 closed out, a net change of +10 holders.
  • The largest Cyteir Therapeutics, Inc. Common Stock buyer in Q4 2021 was Avidity Partners Management, an estimated $2.53M added.
  • The largest Cyteir Therapeutics, Inc. Common Stock seller in Q4 2021 was Fidelity Investments, an estimated $3.61M sold.

Based on aggregated 13F filings for Q4 2021.